Showing 1 - 20 results of 39,782 for search '(( 1 mm decrease ) OR ((( _ em decrease ) OR ( 50 ((a decrease) OR (_ decrease)) ))))*', query time: 0.96s Refine Results
  1. 1

    Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels by Dieter Gerten (557088)

    Published 2013
    “…</strong> Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels. …”
  2. 2
  3. 3

    Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level. by Elena V. Fedorova (603922)

    Published 2014
    “…<p>Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.…”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    The SNP (rs2230500) in <em>PRKCH</em> Decreases the Risk of Carotid Intima-Media Thickness in a Chinese Young Adult Population by Lijun Wu (152858)

    Published 2012
    “…</p> <h3>Conclusions/Significance</h3><p>Our data provide evidence that the SNP (rs2230500) in <em>PRKCH</em> decreases the risk of CIMT that is a worthwhile predictor of stroke and complement system possibly mediates this process.…”
  12. 12

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”